Adaptimmune Therapeutics plc earnings per share and revenue

ADAP earnings per share for the last quarter are -0.01 USD whereas the estimation was -0.01 USD which accounts for -5.74% surprise. Company revenue for the same period amounts to 40.90 M USD despite the estimated figure of 18.96 M USD. Estimated earnings per share for the next quarter are -0.03 USD, and revenue is expected to reach 7.75 M USD. Also watch annual changes over time to get a bigger picture of ADAP earnings per share and revenue dynamics.